Active Ingredient(s): Auranofin
FDA Approved: * May 24, 1985
Pharm Company: * PROMETHEUS LABS
Category: Arthritis

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Ridaura Overview

Auranofin is a gold salt classified by the World Health Organization as an antirheumatic agent. It has the brand name Ridaura. Contents 1 Use 2 Research 2.1 HIV infection 2.2 Amebiasis 2.3 Acanthamoeba Keratitis and Primary Amoebic Meningoencephalitis 2.4 Tuberculosis 2.5 Ovarian cancer 2.6 COVID-19 3 References 4 Further reading 5 External links Use Auranofin is used to treat rheumatoid arthritis. It improves arthritis symptoms including painful or tender and swollen joints and mo...

Read more Ridaura Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Auranofin

Recent Ridaura Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Capsule: 3mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Ridaura: (2 results)

Sorted by National Drug Code
  • 54766-093 Ridaura 3 mg Oral Capsule by Sebela Pharmaceuticals Inc.
  • 65483-093 Ridaura 3 mg Oral Capsule by Prometheus Laboratories Inc.

Other drugs which contain Auranofin or a similar ingredient: (1 result)